Pharmacology 2 Flashcards
Antineoplastic folic acid analog that inhibits dihydrofolate reductase
Methotrexate
Antineoplastic pyrimidine analog that inhibits thymidylate synthetase
5-fluorouracil (5-FU)
Antineoplastic pyrimidine analog that inhibits DNA polymerase
Cytarabine
Serious side effect associated with cytarabine
Pancytopenia
Three antineoplastic purine analogs that inhibit purine synthesis
Azathioprine, 6-mercaptopurine, 6-thioguanine
Drug used concurrently with antineoplastics to reduce renal precipitation of urates
Allopurinol
Two antineoplastics that require dose-reduction in patients who are taking allopurinol
Azathioprine, 6-mercaptopurine
Inhibits microtubule formation by binding to β-tubulin; dose-limiting side effect is bone marrow suppression
Vinblastine
Inhibits microtubule formation by binding to β-tubulin; dose-limiting side effect is neurotoxicity (areflexia, peripheral neuritis, paralytic ileus)
Vincristine
Hyperstabilizes microtubule polymer in M-phase and prevents microtubule breakdown
Paclitaxel, -taxels
Two prodrugs, that after liver bioactivation, bind to N7 nitrogen of guanine and cross-link DNA
Cyclophosphamide, ifosfamide
Serious side effect of cyclophosphamide and ifosfamide due to generation of acrolein
Hemorrhagic Cystitis
Agent that is used to bind acrolein and prevent drug-induced hemorrhagic cystitis
Mesna
Nitrosureas that spontaneously form active intermediates that cross-link DNA; can cross blood-brain-barrier and is indicated for brain tumors
Carmustine, -mustines, streptozocin
Akylating agent that has greater activity against myeloid cells than lymphoid cells; serious side effects include myelosuppression and pulmonary fibrosis
Busulfan
Two anthracyclines that chelate DNA, form free radicals, and cause dose-limiting cardiotoxicity
Daunorubicin, Doxorubicin
Iron-chelator that is used to protect against anthracycline-induced cardio-toxicity
Dexrazoxane
DNA intercalating agent useful for treatment of solid tumors in children
Dactinomycin (actinomycin D)
DNA intercalating agent with minimal myelosuppression that induces formation of free radicals; dose-limiting side effects include pulmonary fibrosis and mucocutaneous reactions
Bleomycin
Antineoplastic with G2 phase cell cycle selectivity
Bleomycin
Ribonucleotide reductase inhibitor with S phase cell cycle selectivity that is used for management of sickle cell anemia
Hydroxyurea
Platinum-derivatives that form DNA intrastrand cross-links; causes dose-limiting nephrotoxicity and ototoxicity
Cisplatin, carboplatin
Two antineoplastics that inhibit topoisomerase I
Irinotecan, topotecan